↓ Skip to main content

Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review

Overview of attention for article published in Critical Care, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 X users
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review
Published in
Critical Care, December 2014
DOI 10.1186/s13054-014-0668-9
Pubmed ID
Authors

Teiji Sawa, Masaru Shimizu, Kiyoshi Moriyama, Jeanine P Wiener-Kronish

Abstract

Pseudomonas aeruginosa uses a complex type III secretion system to inject the toxins ExoS, ExoT, ExoU, and ExoY into the cytosol of target eukaryotic cells. This system is regulated by the exoenzyme S regulon and includes the transcriptional activator ExsA. Of the four toxins, ExoU is characterized as the major virulence factor responsible for alveolar epithelial injury in patients with P. aeruginosa pneumonia. Virulent strains of P. aeruginosa possess the exoU gene, whereas non-virulent strains lack this particular gene. The mechanism of virulence for the exoU+ genotype relies on the presence of a pathogenic gene cluster (PAPI-2) encoding exoU and its chaperone, spcU. The ExoU toxin has a patatin-like phospholipase domain in its N-terminal, exhibits phospholipase A2 activity, and requires a eukaryotic cell factor for activation. The C-terminal of ExoU has a ubiquitinylation mechanism of activation. This probably induces a structural change in enzymatic active sites required for phospholipase A2 activity. In P. aeruginosa clinical isolates, the exoU+ genotype correlates with a fluoroquinolone resistance phenotype. Additionally, poor clinical outcomes have been observed in patients with pneumonia caused by exoU+-fluoroquinolone-resistant isolates. Therefore, the potential exists to improve clinical outcomes in patients with P. aeruginosa pneumonia by identifying virulent and antimicrobial drug-resistant strains through exoU genotyping or ExoU protein phenotyping or both.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Romania 1 <1%
South Africa 1 <1%
Unknown 171 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 40 23%
Student > Master 26 15%
Researcher 18 10%
Student > Bachelor 18 10%
Student > Doctoral Student 16 9%
Other 30 17%
Unknown 27 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 37 21%
Agricultural and Biological Sciences 32 18%
Medicine and Dentistry 30 17%
Immunology and Microbiology 28 16%
Engineering 6 3%
Other 12 7%
Unknown 30 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2015.
All research outputs
#7,205,554
of 25,374,917 outputs
Outputs from Critical Care
#3,995
of 6,554 outputs
Outputs of similar age
#89,876
of 361,008 outputs
Outputs of similar age from Critical Care
#77
of 132 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,008 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.